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Abstract: Physical exercise is known to promote beneficial effects on overall health, counteracting
risks related to degenerative diseases. MicroRNAs (miRNAs), short non-coding RNAs affecting
the expression of a cell’s transcriptome, can be modulated by different stimuli. Yet, the molecular
effects on osteogenic differentiation triggered by miRNAs upon physical exercise are not completely
understood. In this study, we recruited 20 male amateur runners participating in a half marathon.
Runners’ sera, collected before (PRE RUN) and after (POST RUN) the run, were added to cultured
human mesenchymal stromal cells. We then investigated their effects on the modulation of selected
miRNAs and the consequential effects on osteogenic differentiation. Our results showed an increased
expression of miRNAs promoting osteogenic differentiation (miR-21-5p, miR-129-5p, and miR-378-5p)
and a reduced expression of miRNAs involved in the adipogenic differentiation of progenitor cells
(miR-188-5p). In addition, we observed the downregulation of PTEN and SMAD7 expression
along with increased AKT/pAKT and SMAD4 protein levels in MSCs treated with POST RUN sera.
The consequent upregulation of RUNX2 expression was also proven, highlighting the molecular
mechanisms by which miR-21-5p promotes osteogenic differentiation. In conclusion, our work
proposes novel data, which demonstrate how miRNAs may regulate the osteogenic commitment of
progenitor cells in response to physical exercise.
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1. Introduction
Bone formation and homeostasis are complex processes controlled by hormones, growth
factors, signaling factors, and environmental factors. Bone homeostasis is achieved thanks to the
cross-talk occurring between osteoblasts, osteocytes (mechanosensing osteoblasts embedded within the
mineralized matrix), and osteoclasts (large multinucleated bone resorbing cells which differentiate from
the monocyte/macrophage lineage). Osteoblasts derive from pluripotent bone marrow mesenchymal
stromal cells (MSCs), which can differentiate into adipocytes, chondrocytes, or osteoblasts. Multiple
signaling pathways control the mutually exclusive fates of progenitors by triggering the expression of
master genes coding for specific transcription factors. Expression of the Runt-related transcription
factor 2 (RUNX2) is essential for the osteogenic commitment; expression of a down-stream transcription
factor, Osterix (SP7) allows osteoblastic maturation. Mature osteoblasts then express genes for matrix
biosynthesis and mineralization, such as collagen type I genes (COL1A1/COL1A2), Osteocalcin (OCN),
Osteopontin (SPP1), Osteonectin (SPARC), and others [1].
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Notably, osteogenesis is regulated also at a post-transcriptional level. MicroRNAs (miRNAs) can
interfere with mRNAs translation. Their role in controlling bone formation and homeostasis has been
widely investigated [2]. In particular, it has been recognized that both specific transcription factors
and miRNAs control mesenchymal cells commitment and differentiation, osteoblast and osteocyte
functions, as well as osteoclast maturation [3]. Among miRNAs promoting osteogenic differentiation of
progenitor cells, miR-21-5p, a ubiquitously expressed microRNA, plays an important role. One of miR-21
targets, Smad7, is an inhibitory member of the Smad proteins’ family, which antagonizes TGF-beta
signaling [4,5]. Another player, miR-129-5p, promotes osteogenic differentiation of progenitor cells by
targeting STAT 1, a transcriptional repressor of RUNX2 [6]. MiR-378 has been found to be overexpressed
in BMP2-induced osteogenic differentiation of mesenchymal stromal cells [7]. MiR-188-5p, instead,
seems to act as an important regulator of the mutually exclusive osteogenic/adipogenic commitment of
progenitors. MiR-188-5p upregulation promotes PPARG expression, i.e., adipogenic differentiation [8].
Among the environmental factors influencing bone formation and quality, physical exercise
certainly plays a fundamental role. Physical exercise enhances bone mineral density and can stimulate
mesenchymal stromal cells mobilization and osteogenic commitment, to the exclusion of adipogenic
commitment [9]. Recently, we have shown that the half marathon trial significantly enhances the
expression of RUNX2 in amateur runners, as well as the calcification process in an in vitro model [10].
The present study was designed to further investigate the effects of the half marathon effort on MSCs
alternative osteogenic/adipogenic commitment. For this purpose, cultures of a human bone marrow
MSC line (hBMMSC) were supplemented with sera obtained from runners before (PRE RUN) and
after (POST RUN) the marathon. MSC commitment and differentiation pathways were monitored by
selected miRNAs’ expression analysis along with specific marker genes/proteins expression analysis.
2. Materials and Methods
2.1. Subjects
Twenty male runners were included in the study. Study subjects were enrolled during sport
events called ‘Run For Science’, held in Verona (Italy) in April 2016 and April 2017. The twenty male
amateur runners (median age 40.2 ± 8) carried out a 21.1 Km half marathon. Written informed consent
was obtained from all participants and the study was approved by the Ethical Committee of Azienda
Ospedaliera Universitaria Integrata of Verona, Italy (number 1538).
2.2. Sera Collection
Peripheral blood samples were collected before the run and immediately after. All participants
gave informed consent. Sera were obtained from 10 mL of fresh blood by centrifugation at 400× g.
Then, sera were harvested and frozen in aliquots at −80 ◦C until use.
2.3. In Vitro Treatments
Pooled sera were added to the Mesenchimal Stem Cell Grow Medium (PromoCell, GMBH
Heidelberg, Germany) at 10% of final concentration. Cells were plated at density of 5 × 104 cells
per well into 24-well plates. The osteogenic differentiation was performed with osteogenic medium
containing Osteogenic Stimulatory Supplements (15% Stemcell), 10−8 M dexamethasone, 3.5 mM
β-glycerophosphate, and 50 µg/mL ascorbic acid (StemCell Technologies Inc, Vancouver, British
Columbia, Canada) Adipogenic differentiation was performed by using isobutylmethylxanthine
(0.5 mM), indomethacin (200 µM), dexamethasone (10−6 M), and insulin (10 µg/mL) in basal medium.
For both osteogenic and adipogenic differentiation, the medium was changed every 3 days after
initial plating.
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2.4. Total RNA Extraction
Total RNA was extracted from each cell pellet using the RNA assay Minikit (Quiagen Italia,
Milano, Italy) with DNAse I treatment. This kit provokes cell membrane breaks. Cell components
obtained were then filtrated on QIAshredder columns, capable of binding nucleic acid. These can be
then collected after washing and separation from other cell components. The amount of obtained RNA
was quantified by measuring the absorbance at 260 nm. The purity of RNA was checked by calculating
the ratio of the absorbance at 260 and 280 nm, with a ratio ranging from 1.8 to 2.0 taken to be pure.
2.5. Reverse Transcription
First-strand cDNA was generated, according to manufacturer’s protocol, using the First Strand
cDNA Synthesis Kit (GE Healthcare, Italia, Milano, Italy) with random hexamers, reverse transcriptase,
and 4 dNTPs. To RNA 1 µg, heated up to 65 ◦C for 10 min, kit components were added. Sample was
then taken at 37 ◦C for 1 h. RT product was aliquoted in equal volumes and then stored at −80 ◦C.
2.6. Real Time RT-PCR
PCR was performed in a total volume of 50 µL containing 1x Taqman Universal PCR Master
Mix, no AmpErase UNG, and 5 µL of cDNA from each sample. The following pre-designed, specific
primers and probe set were obtained from Assay-on-Demand Gene Expression (Thermofisher Scientific
Waltham, MA, USA) RUNX2, hs00231692m1; PPARG, hs01115513m1; PTEN, hs02621230m1; SMAD7,
hs 00998193m1; miR-21-5p, TM.000397; miR-188-5p, TM 002320; miR-129-5p, TM 000590; miR-378-5p,
TM.000567; B2M, hs999999m1, GAPDH, 0802021; RNU44, TM 001094. Real Time RT-PCR reactions
were carried out in multiplex. The real time amplifications included 10 min at 95 ◦C, followed by
40 cycles at 95 ◦C for 15 s, and at 60 ◦C for 1 min. Thermocycling and signal detection were performed
with ABI Prism 7300 Sequence Detector and signals were detected as we previously reported [11].
The expression levels were calculated for each sample in triplicate after normalization against the
housekeeping genes (β2 microglobulin and GADPH for mRNA or RNU44 for miRNAs), using the
relative fold expression differences.
2.7. Western Blotting
Protein extraction was performed using Ripa buffer (Thermo Fisher Scientific, Waltham, MA,
USA) according to the manufacturer’s protocol. Protein concentrations were calculated by performing
a BCA assay (Thermo Scientific, Waltham, MA, USA). Protein samples were diluted in 4x Laemmli’s
sample buffer (Biorad, CA, US), heated for 5 min at 95 ◦C, and separated by sodium dodecyl
sulfate−polyacrylamide gel electrophoresis (SDS PAGE), using a mini-PROTEAN ®TGXTM Precast
gradient 4–20% gel (Biorad, CA, US), followed by transfer onto polyvinylidene difluoride (PVDF)
membranes (Thermo Fisher Scientific, Waltham, MA, USA). PVDF membranes were probed with the
primary (anti-Caspase-3 antibody [EPR18297] (Abcam ab184787; Cambridge, UK) (AKT (C67E7), (Cell
Signaling, 4691); pAKT (193H12), Cell Signaling, 4058; SMAD4 (B-8), (SantaCruz Biotech., Dallas,
TX, USA; β ACTIN (BA3R), (Thermo Scientific, Waltham, MA, USA); and secondary antibodies
(Anti-rabbit (Cell Signaling, 7074); Anti-mouse (Cell Signaling, 7076). Signals were detected using a
chemiluminescence reagent (ECL, Millipore, Burlington, MA, USA) according to the manufacturer’s
instructions. Images were acquired using a LAS4000 Digital Image Scanning System (GE Healthcare,
Little Chalfont, UK). Densitometric analysis was performed by using ImageQuant software (GE
Healthcare, Little Chalfont, UK), and the relative protein band intensity was normalized to β ACTIN
as we previously reported [12].
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2.8. Alizarin Red Staining
Calcium deposition was evaluated after 21 days of culture by the alizarin red staining as
we previously reported [13]. Briefly, cells were fixed with 70% ethanol, washed with water, and
stained for 5 min with 40 mM Alizarin Red S at pH 4.1. Then, the cells were rinsed with 1×
phosphate-buffered saline.
2.9. Oil Red O Staining
Lipid droplets were stained using the Oil Red O, according to the manufacturer’s instructions.
The total area of red pixels in the Oil Red O-stained droplets/cell was determined by using the IMAGE
J image analysis as previously reported [13]. In particular, positively stained areas were expressed as
percentage respect to total area. In addition, we calculated the number of lipid droplets for each cell as
previously reported [14].
2.10. Statistic Analysis
Statistic analyses were performed using SPSS 21.0 for Windows operative system. To compare all
variables we used Student T test, considering statistically relevant p values < 0.05. Results were expressed
as Mean ± Standard Deviation. To evaluate any variable relation, we used bivariate correlation.
3. Results
3.1. Expression of miRNAs in Osteoprogenitor Cells
To evaluate the effects of physical exercise on osteo-miRNAs modulation, we analyzed the
expression of miR-21-5p, miR-129-5p, miR-188-5p, and miR-378-5p, respectively, which are known to be
involved in osteogenic differentiation and modulation [5–8]. As reported in Figure 1, expression levels
of miR-21-5p were higher in MSCs treated with POST RUN sera compared to cells treated with PRE
RUN sera after 7 (p < 0.01), 14 (p < 0.05), and 21 (p < 0.01) days of differentiation. Similarly, miR-129-5p
expression levels were higher in MSCs treated with POST RUN sera after 14 days of differentiation
(p < 0.01). No differences were observed after 7 or 21 days of differentiation. Conversely, miR-188-5p
expression appeared significantly downregulated after 14 and 21 days of osteogenic differentiation
(p < 0.05). MiR-378-5p was not detected after 7 days of differentiation in MSCs treated either with PRE
RUN or POST RUN sera. It appeared to be upregulated after 14 (p < 0.05) and 21 (p < 0.05) days of
differentiation in the presence of POST RUN sera.
3.2. Osteogenic Differentiation of Mesenchimal Stromal Cells
The enhanced osteogenic differentiation of MSCs treated with POST RUN sera suggested by
miRNAs modulation was confirmed by the upregulation of RUNX2 expression (Figure 2A), and
by the increased number of bone nodule formation evaluated by Alizarin Red staining (Figure 2B).
Accordingly, upregulation of COL1A2 (collagen type I alpha 2 chain; Figure 2D) and of IBSP (bone
sialoprotein 2; Figure 2C) gene expression, and increased OCN (Osteocalcin) protein levels (Figure 2E)
confirm the production of bone ECM proteins.
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Figure 2. Upregulation of RUNX2 was observed in MSCs treated with POST RUN compared to PRE
RUN sera (A). Bone nodule formation ability assessed by Alizarin Red S was in POST RUN sera MCSs
(B). Increased osteogenic differentiationin in POST RUN sera MSCs was confirmed by the upregulation
of Collagen type I alpha 2 chain (COL1A2; C) and Integrin Binding Sialoprotein (IBSP D) as well
as by increased protein levels of Osteocalcin (OCN) (E) Data were collected from three independent
experiments. OD: optical density; * p < 0.05 and ** p < 0.01.
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Treatment of MSCs with POST RUN sera protected them from apoptosis. In fact, a lower cleaved
caspase-3/caspase-3 ratio was observed in POST RUN compared to PRE RUN-sera treated MSCs
(Figure 3A). The downregulation of PPARG2 expression (Figure 3B) and reduced oil droplets evaluated
by the Oil Red O staining (Figure 3C), suggest reduced adipogenic commitment in MSCs treated with
POST RUN sera.Cells 2019, 8, x 7 of 12 
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Figure 3. Cleaved caspase-3/caspase-3 ratio was reduced in MSCs treated with POST RUN sera
(A) PPARG was downregulated in MSCs treated with POST RUN sera (B). The reduced adipogenic
commitment was confirmed by a reduced number of lipid droplets for cells as well as the % of Oil Red
O positive stained area (C). Data were collected from three independent experiments. * p < 0.05 and
** p < 0.01.
3.3. MiR-21-5p Promotes Osteogenic Differentiation by Targeting PTEN and SMAD7 mRNAs
In order to further explore miR-21-5p’s action towards osteogenic differentiation, we analyzed the
expression of PTEN and SMAD7 genes. Both PTEN (Figure 4A) and SMAD7 (Figure 4B) RNA levels
were reduced in MSCs treated with POST RUN sera. In addition, AKT and pAKT (Figure 4C) as well
as SMAD4 (Figure 4D) protein levels increased in MSCs treated with POST RUN sera.
The observed AKT protein increase, along with a significant reduction of PTEN mRNA levels,
suggest that physical exercise promotes the AKT pathway by upregulating miR-21-5p (Figure 5).
In addition, miR-21-5p-driven SMAD7 reduction leads the way to SMAD4 increase. It appears, therefore,
that miR-21-5p stimulates osteogenic differentiation through at least two different routes. It is known
that both the AKT and SMAD pathways upregulate the osteogenesis master gene RUNX2 expression.
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4. Discussion
Recently, the regulatory functions of epigenetic factors such as miRNAs in physiological and
pathological processes have been widely investigated. In particular, modulation of miRNAs following
physical exercise represents an interesting field of investigation since these non-coding RNAs may
be considered as defenders against degenerative diseases, as well as useful prognostic markers [15].
Different studies have shown that miRNAs can be recovered from peripheral blood and analyzed
as biomarkers in several biomedical fields. In particular, previous studies show the modulation
of circulating miRNA following exercise and chronic endurance. The upregulation of miR–338-3p,
miR-330-3p, miR-223, miR-139-5p, miR-143 has been reported after 1 h of exercise [16]. Interestingly,
it has been reported that miR-223 is involved in bone metabolism and in particular in osteoclasts and
osteoblast differentiation [17]. Therefore, the upregulation of miR-223 following exercise suggests the
induction of bone remodeling after physical activity. Moreover, increased expression of miR-21-5p
and miR-378-5p in serum has been reported after acute exhaustive exercise [7]. Both miR-21-5p and
miR-3785p play an important role in osteogenesis [5,7]. Accordingly, it has been reported that physical
exercise plays a fundamental role in promoting mobilization of mesenchymal stem cells and their
osteogenic commitment [9].
In this work we have demonstrated how the addition of POST RUN sera to cultured MSCs
modulates the expression of miRNAs promoting osteogenic differentiation. Notably, the upregulation
of miRNAs promoting osteogenic commitment of progenitors occurred at the expense of the mutually
exclusive adipogenic commitment.
We monitored the cellular response to POST RUN sera exposure by measuring the expression
levels of selected miRNAs. In particular, the expression of miR-21-5p, miR-129-5p, and miR-378-5p,
were found to be upregulated in cells treated with POST RUN sera. The role of these miRNAs in
promoting osteoblast differentiation has been broadly reported [5,7,18]. Li et al. showed that miR-21
promotes osteogenesis by inducing RUNX2 via the Smad7-Smad1/5/8 pathways [4]. Furthermore, it has
been reported that miR-378 activates the PI3K/Akt pathway by targeting CASP3 [19], and miR-129
enhances RUNX2 expression by targeting STAT1, a transcriptional repressor of RUNX2 [6]. Our data
show timing differences in their modulation during the osteogenic differentiation process of MSCs,
monitored at the proliferative (7 days) and mineralization (14–21 days) stages.
We focused mainly on miR-21-5p’s modes of action, considering its persistent upregulation
during the 21 days of differentiation period. MiR-21-5p is known to regulate cellular proliferation,
invasion, and migration, by targeting the two TGF-beta pathway antagonists: PTEN and Smad7 [20].
MiR-21-5p’s positive role in promoting the osteogenic commitment of bone marrow stem cells has
been demonstrated in vitro as well as in animal models [4,21,22]. Our experiments demonstrate that
miR-21-5p upregulation induced by physical exercise, also promoted osteogenic differentiation through
the AKT and SMAD pathways.
It has been suggested that increased levels of circulating miR-21 occur during physical exercise
as a consequence of endothelial cells apoptosis following exercise [23]. In our study, we found
that MSCs treated with POST RUN sera had a reduced tendency for apoptosis. This finding is in
agreement with the described role of miR-21 in inhibiting apoptosis in mesenchymal stem cells via
PTEN down-regulation [24]. Moreover, a study related to three protocols involving different muscular
work reported that miR-21 levels decreased after the exercise, while increasing during the recovery.
The authors suggest that miR-21 is involved in pro-inflammatory as well as in immunoregulatory
anti-inflammatory processes [25].
Notably, we found that miR-188-5p expression was instead downregulated during the
differentiation process of MSCs treated with POST RUN sera. The dowregulation of miR-188-5p is in
agreement with the increased levels of AKT/pAKT observed in MSCs treated with POST RUN sera.
In fact, it has been demonstrated that miR-188-5p reduces the PI3K/AKT signaling pathway [26,27].
MiR-188-5p has been suggested to play a regulatory role in promoting the adipogenesis versus
osteogenesis switch [8]. In particular, it has been demonstrated that miR-188-5p contributes to bone
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ageing by increasing the number of adipocytes at the expense of osteoblasts. Indeed, the downregulation
of miR-188-5p following physical exercise can be considered as a desirable effect counteracting
age-related bone deterioration.
It has also been demonstrated that miR-129-5p inhibits preadipocyte proliferation by targeting
G3BP1 (GTPase-activating protein SH3 domain-binding protein 1) [28]. Our data confirm that:
miR-188-5p downregulation and miR-129-5p upregulation, as a consequence of physical exercise, lead
to reduced expression of PPARG2, the master regulator of adipogenesis and to a reduced proliferation
of adipocytes. Finally miR-378-5p upregulation not only promotes osteogenic differentiation [7], but is
also involved in brown adipogenesis [29,30]. This finding is in agreement with the positive role of
physical exercise in counteracting obesity. Therefore, we can speculate that physical exercise reduces
adipogenesis in general and increases the brown fat component.
In conclusion, our work exemplifies the important regulatory roles played by a few selected
miRNAs. They may be also considered very useful markers for the monitoring of osteogenic versus
adipogenic commitment of progenitor cells in response to diverse environmental stimuli.
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PTEN Phosphatase and Tensin homolog
RUNX2 Runt-related transcription factor 2





1. Valenti, M.T.; Dalle Carbonare, L.; Mottes, M. Osteogenic Differentiation in Healthy and Pathological
Conditions. Int. J. Mol. Sci. 2016, 18, 41. [CrossRef] [PubMed]
2. Peng, S.; Gao, D.; Gao, C.; Wei, P.; Niu, M.; Shuai, C. MicroRNAs regulate signaling pathways in osteogenic
differentiation of mesenchymal stem cells (Review). Mol. Med. Rep. 2016, 14, 623–629. [CrossRef] [PubMed]
3. Valenti, M.T.; Dalle Carbonare, L.; Mottes, M. Role of microRNAs in progenitor cell commitment and
osteogenic differentiation in health and disease (Review). Int. J. Mol. Med. 2018, 41, 2441–2449. [CrossRef]
[PubMed]
Cells 2019, 8, 742 10 of 11
4. Li, X.; Guo, L.; Liu, Y.; Su, Y.; Xie, Y.; Du, J.; Zhou, J.; Ding, G.; Wang, H.; Bai, Y. MicroRNA-21 promotes
osteogenesis of bone marrow mesenchymal stem cells via the Smad7-Smad1/5/8-Runx2 pathway. Biochem.
Biophys. Res. Commun. 2017, 493, 928–933. [CrossRef] [PubMed]
5. Arumugam, B.; Balagangadharan, K.; Selvamurugan, N. Syringic acid, a phenolic acid, promotes osteoblast
differentiation by stimulation of Runx2 expression and targeting of Smad7 by miR-21 in mouse mesenchymal
stem cells. J. Cell Commun. Signal 2018, 12, 561–573. [CrossRef] [PubMed]
6. Xiao, W.Z.; Gu, X.C.; Hu, B.; Liu, X.W.; Zi, Y.; Li, M. Role of microRNA-129-5p in osteoblast differentiation
from bone marrow mesenchymal stem cells. Cell Mol. Biol. 2016, 62, 95–99. [PubMed]
7. Hupkes, M.; Sotoca, A.M.; Hendriks, J.M.; van Zoelen, E.J.; Dechering, K.J. MicroRNA miR-378 promotes
BMP2-induced osteogenic differentiation of mesenchymal progenitor cells. BMC Mol. Biol. 2014, 15, 1.
[CrossRef] [PubMed]
8. Li, C.J.; Cheng, P.; Liang, M.K.; Chen, Y.S.; Lu, Q.; Wang, J.Y.; Xia, Z.Y.; Zhou, H.D.; Cao, X.; Xie, H.; et al.
MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J. Clin. Investig.
2015, 125, 1509–1522. [CrossRef] [PubMed]
9. Maredziak, M.; Smieszek, A.; Chrzastek, K.; Basinska, K.; Marycz, K. Physical Activity Increases the Total
Number of Bone-Marrow-Derived Mesenchymal Stem Cells, Enhances Their Osteogenic Potential, and
Inhibits Their Adipogenic Properties. Stem Cells Int. 2015, 379093, 16. [CrossRef] [PubMed]
10. Dalle Carbonare, L.; Manfredi, M.; Caviglia, G.; Conte, E.; Robotti, E.; Marengo, E.; Cheri, S.; Zamboni, F.;
Gabbiani, D.; Deiana, M.; et al. Can half-marathon affect overall health? The yin-yang of sport. J. Proteom.
2018, 170, 80–87. [CrossRef]
11. Valenti, M.T.; Dalle Carbonare, L.; Donatelli, L.; Bertoldo, F.; Zanatta, M.; Lo Cascio, V. Gene expression
analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells. Bone 2008, 43,
1084–1092. [CrossRef] [PubMed]
12. Deiana, M.; Dalle Carbonare, L.; Serena, M.; Cheri, S.; Parolini, F.; Gandini, A.; Marchetto, G.; Innamorati, G.;
Manfredi, M.; Marengo, E.; et al. New Insights into the Runt Domain of RUNX2 in Melanoma Cell
Proliferation and Migration. Cells 2018, 7, 220. [CrossRef] [PubMed]
13. Valenti, M.T.; Garbin, U.; Pasini, A.; Zanatta, M.; Stranieri, C.; Manfro, S.; Zucal, C.; Carbonare, L.D. Role
of Ox-PAPCs in the Differentiation of Mesenchymal Stem Cells (MSCs) and Runx2 and PPAR gamma 2
Expression in MSCs-Like of Osteoporotic Patients. PLoS ONE 2011, 6, e20363. [CrossRef] [PubMed]
14. Scott, C.C.; Vossio, S.; Rougemont, J.; Gruenberg, J. TFAP2 transcription factors are regulators of lipid droplet
biogenesis. Elife 2018, 7, e36330. [CrossRef] [PubMed]
15. Altana, V.; Geretto, M.; Pulliero, A. MicroRNAs and Physical Activity. Microrna 2015, 4, 74–85. [CrossRef]
[PubMed]
16. Nielsen, S.; Akerstrom, T.; Rinnov, A.; Yfanti, C.; Scheele, C.; Pedersen, B.K.; Laye, M.J. The miRNA plasma
signature in response to acute aerobic exercise and endurance training. PLoS ONE 2014, 9, e87308. [CrossRef]
[PubMed]
17. Xie, Y.; Zhang, L.; Gao, Y.; Ge, W.; Tang, P. The Multiple Roles of Microrna-223 in Regulating Bone Metabolism.
Molecules 2015, 20, 19433–19448. [CrossRef] [PubMed]
18. Sera, S.R.; Zur Nieden, N.I. microRNA Regulation of Skeletal Development. Curr. Osteoporos. Rep. 2017, 15,
353–366. [CrossRef] [PubMed]
19. You, L.; Gu, W.; Chen, L.; Pan, L.; Chen, J.; Peng, Y. MiR-378 overexpression attenuates high
glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K/Akt signaling
pathway. Int. J. Clin. Exp. Pathol. 2014, 7, 7249–7261. [PubMed]
20. Luo, M.; Tan, X.; Mu, L.; Luo, Y.; Li, R.; Deng, X.; Chen, N.; Ren, M.; Li, Y.; Wang, L.; et al. MiRNA-21
mediates the antiangiogenic activity of metformin through targeting PTEN and SMAD7 expression and
PI3K/AKT pathway. Sci. Rep. 2017, 7, 43427. [CrossRef]
21. Chen, D.; Wang, Z. Adrenaline inhibits osteogenesis via repressing miR-21 expression. Cell Biol. Int. 2017, 41,
8–15. [CrossRef] [PubMed]
22. Yang, C.; Liu, X.; Zhao, K.; Zhu, Y.; Hu, B.; Zhou, Y.; Wang, M.; Wu, Y.; Zhang, C.; Xu, J.; et al. miRNA-21
promotes osteogenesis via the PTEN/PI3K/Akt/HIF-1alpha pathway and enhances bone regeneration in
critical size defects. Stem Cell Res. Ther. 2019, 10, 65. [CrossRef] [PubMed]
Cells 2019, 8, 742 11 of 11
23. Wahl, P.; Wehmeier, U.F.; Jansen, F.J.; Kilian, Y.; Bloch, W.; Werner, N.; Mester, J.; Hilberg, T. Acute Effects of
Different Exercise Protocols on the Circulating Vascular microRNAs -16, -21, and -126 in Trained Subjects.
Front. Physiol. 2016, 7, 643. [CrossRef] [PubMed]
24. Lv, C.; Hao, Y.; Han, Y.; Zhang, W.; Cong, L.; Shi, Y.; Tu, G. Role and mechanism of microRNA-21 in
H2O2-induced apoptosis in bone marrow mesenchymal stem cells. J. Clin. Neurosci. 2016, 27, 154–160.
[CrossRef] [PubMed]
25. Cui, S.; Sun, B.; Yin, X.; Guo, X.; Chao, D.; Zhang, C.; Zhang, C.Y.; Chen, X.; Ma, J. Time-course responses of
circulating microRNAs to three resistance training protocols in healthy young men. Sci. Rep. 2017, 7, 2203.
[CrossRef] [PubMed]
26. Zhang, H.; Qi, S.; Zhang, T.; Wang, A.; Liu, R.; Guo, J.; Wang, Y.; Xu, Y. miR-188-5p inhibits tumour growth and
metastasis in prostate cancer by repressing LAPTM4B expression. Oncotarget 2015, 6, 6092–6104. [CrossRef]
[PubMed]
27. Zhu, W.; Wu, X.; Yang, B.; Yao, X.; Cui, X.; Xu, P.; Chen, X. miR-188-5p regulates proliferation and invasion via
PI3K/Akt/MMP-2/9 signaling in keloids. Acta Biochim. Biophys. Sin. (Shanghai) 2019, 51, 185–196. [CrossRef]
28. Lv, S.; Ma, M.; Sun, Y.; Wang, X.; Qimuge, N.; Qin, J.; Pang, W. MicroRNA-129-5p inhibits 3T3-L1 preadipocyte
proliferation by targeting G3BP1. Anim. Cells Syst. (Seoul) 2017, 21, 269–277. [CrossRef]
29. Kim, J.; Okla, M.; Erickson, A.; Carr, T.; Natarajan, S.K.; Chung, S. Eicosapentaenoic Acid Potentiates Brown
Thermogenesis through FFAR4-dependent Up-regulation of miR-30b and miR-378. J. Biol. Chem. 2016, 291,
20551–20562. [CrossRef]
30. Pan, D.; Mao, C.; Quattrochi, B.; Friedline, R.H.; Zhu, L.J.; Jung, D.Y.; Kim, J.K.; Lewis, B.; Wang, Y.X.
MicroRNA-378 controls classical brown fat expansion to counteract obesity. Nat. Commun. 2014, 5, 4725.
[CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
